Filaggrin loss-of-function mutations 2282del4, R501X, R2447X and S3247X in atopic dermatitis

Author:

Verbenko DA1ORCID,Karamova AE1ORCID,Chickin VV1,Kozlova IV1,Aulova KM1ORCID,Kubanov AA1ORCID,Gorodnichev PV1

Affiliation:

1. State Research Center of Dermatovenereology and Cosmetology of the Ministry of Health of the Russian Federation

Abstract

Atopic dermatitis (AD) is a widespread multifactorial genetically determined inflammatory skin disease caused by, among other causes, impaired functions of the epidermal barrier. Loss-of-function mutations of the filaggrin gene (important component of the natural moisturizing factor system) that arrest production of the full-fledged precursor protein are associated with AD. This work investigated the frequency of the 2282delACTG (rs558269137), R501X (rs61816761), S3247X (rs150597413), R2447X (rs138726443) loss-of-function mutations of the filaggrin gene in adult European patients with moderate to severe AD. The study involved 99 adult patients of both sexes aged 18-68 years. The mutations were identified with the help of the purpose-developed method of multiplex analysis of four single nucleotide polymorphisms that relies on the SNaPshot technique (minisequencing). The incidence of loss-of-function mutation of filaggrin 2282delACTG was 5.3%, that of R501X - 0.5%, R2447X - 1%. No S3247X mutation was detected in the sample. Collation of the results with Russian and European samples revealed a comparable level of the analyzed filaggrin gene mutations in adult patients with AD from different regions of the Russian Federation.

Publisher

Pirogov Russian National Research Medical University

Reference40 articles.

1. Zaslavskij DV, Svitich OA, Kudrjavceva AV. Atopicheskij dermatit. Mezhdisciplinarnyj podhod k diagnostike i lecheniju: Rukovodstvo dlja vrachej. Moskva: GJeOTAR-Media, 2024; 288 s. Russian.

2. Klinicheskie rekomendacii. Atopicheskij dermatit. Utverzhdeny Minzdravom RF. Dostupno po ssylke: https://www.nrcii.ru/specialistam/klinrecommend/atopic_dermatitis_2020.pdf. Russian.

3. Kubanov AA, Bogdanova EV. Resursy i rezul'taty dejatel'nosti medicinskih organizacij, okazyvajushhih medicinskuju pomoshh' po profilju «dermatovenerologija», v Rossijskoj Federacii v 2016–2022 gg. Vestnik dermatologii i venerologii. 2023; 99 (4): 18–40. Dostupno po ssylke: https://doi.org/10.25208/vdv12385. Russian.

4. Kotova EG, Kobjakova OS, Kubanov AA, Starodubov VI, Aleksandrova GA, Bogdanova EV, i dr. Resursy i dejatel'nost' medicinskih organizacij dermatovenerologicheskogo profilja. Zabolevaemost' infekcijami, peredavaemymi polovym putem, zaraznymi kozhnymi boleznjami i boleznjami kozhi v 2022 godu: statisticheskie materialy. M.: FGBU «CNIIOIZ» Minzdrava Rossii, 2023; 209 s. DOI: 10.21045/978-5-94116-130-0-2023. Russian.

5. Traidl S, Freimooser S, Werfel T. Janus kinase inhibitors for the therapy of atopic dermatitis. Allergol Select. 2021; 5: 293–304. DOI: 10.5414/ALX02272E.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3